MX9205549A - Metodo para el tratamiento de vih. - Google Patents

Metodo para el tratamiento de vih.

Info

Publication number: MX9205549A
Authority: MX; Mexico
Prior art keywords: treatment; hiv; undergoing; compounds capable; hiv infections
Prior art date: 1991-09-30

Application number

MX9205549A

Other languages

English (en)

Inventor

Jess G Thoene

Original Assignee

Jess G Thoene

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-30

Filing date

1992-09-29

Publication date

1993-05-01

1992-09-29 Application filed by Jess G Thoene filed Critical Jess G Thoene

1993-05-01 Publication of MX9205549A publication Critical patent/MX9205549A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Medicines Containing Plant Substances (AREA)
External Artificial Organs (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

MX9205549A 1991-09-30 1992-09-29 Metodo para el tratamiento de vih. MX9205549A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US76780291A	1991-09-30	1991-09-30
US86521992A	1992-04-08	1992-04-08

Publications (1)

Publication Number	Publication Date
MX9205549A true MX9205549A (es)	1993-05-01

Family

ID=27117960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9205549A MX9205549A (es)	1991-09-30	1992-09-29	Metodo para el tratamiento de vih.

Country Status (11)

Country	Link
EP (1)	EP0607252B1 (es)
JP (1)	JPH06511008A (es)
AT (1)	ATE173625T1 (es)
AU (1)	AU675412B2 (es)
BR (1)	BR9206571A (es)
CA (1)	CA2120140A1 (es)
DE (1)	DE69227696T2 (es)
MX (1)	MX9205549A (es)
OA (1)	OA09917A (es)
PT (1)	PT100914A (es)
WO (1)	WO1993006832A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9303854D0 (en) *	1993-02-25	1993-04-14	Holt John A G	Method for enhancing t-cell count
EP0789565A4 (en) *	1993-10-15	1999-03-24	Jess G Thoene	PREVENTION OF HIV INFECTION
US5725870A (en) *	1993-10-15	1998-03-10	Thoene; Jess G.	Methods, composites and articles for contraception
KR100227095B1 (ko) *	1994-01-26	1999-10-15	토미모토 요시히사	항 hiv제
US5734081A (en) *	1994-08-05	1998-03-31	Warner-Lambert Company	Arylthio compounds
US5463122A (en) *	1994-08-05	1995-10-31	Warner-Lambert Company	Arylthio compounds
US5846958A (en) *	1995-02-17	1998-12-08	U.S. Bioscience, Inc.	Methods of using aminothiols to promote hematopoietic progenitor cell growth
EP0868900A1 (de) *	1997-03-14	1998-10-07	Wella Aktiengesellschaft	Mittel und Verfahren zur daurerhaften Haarverformung
JP3012923B2 (ja)	1998-01-26	2000-02-28	新潟大学長	Ｃａｇリピート病の治療薬
US6600076B1 (en)	1999-04-05	2003-07-29	The Regents Of The University Of California	Cleavable, water-soluble surfactants
WO2004024129A1 (en) *	2002-09-10	2004-03-25	Samir Chachoua	Induced remission therapy
AR057623A1 (es) *	2005-11-28	2007-12-05	Omega Bio Pharma H K Ltd	Materiales y metodos para el tratamiento de las infecciones virales
WO2010138419A2 (en) *	2009-05-23	2010-12-02	Obio Pharmaceutical (H.K.) Ltd.	Materials and methods for treating viral infections
WO2011046901A2 (en) *	2009-10-12	2011-04-21	Walker Dale M	Broad spectrum antiviral and methods of use
RU2022103033A (ru) *	2015-07-02	2022-04-01	ХОРАЙЗОН ОРФАН ЭлЭлСи	Цистеаминдиоксигеназа-резистентные аналоги цистеамина и их применение
IL261756B2 (en)	2016-03-17	2023-11-01	Thiogenesis Therapeutics Inc	Preparations for the controlled release of cysteamine and systemic treatment of disorders sensitive to cysteamine
CN118924717A (zh)	2017-09-20	2024-11-12	硫创治疗公司	用于治疗半胱胺敏感性病症的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1055560B (it) *	1974-05-02	1982-01-11	Istituto Chemioterapico	Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
ATE73995T1 (de) *	1985-06-08	1992-04-15	Asta Medica Ag	Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.
CA1339070C (en) *	1989-01-26	1997-07-29	Wulf Droge	Treatment of diseases associated with cysteine deficiency
WO1990014007A1 (en) *	1989-05-24	1990-11-29	U.S. Bioscience	Method for protection from azt side effects and toxicity
EP0656787A1 (en) *	1992-08-19	1995-06-14	Trustees Of Boston University	Method of inhibiting reduction of disulfide bonds

1992
- 1992-09-29 MX MX9205549A patent/MX9205549A/es unknown
- 1992-09-29 PT PT100914A patent/PT100914A/pt not_active Application Discontinuation
- 1992-09-30 EP EP92921278A patent/EP0607252B1/en not_active Expired - Lifetime
- 1992-09-30 AT AT92921278T patent/ATE173625T1/de not_active IP Right Cessation
- 1992-09-30 BR BR9206571A patent/BR9206571A/pt not_active Application Discontinuation
- 1992-09-30 CA CA002120140A patent/CA2120140A1/en not_active Abandoned
- 1992-09-30 JP JP5506962A patent/JPH06511008A/ja active Pending
- 1992-09-30 WO PCT/US1992/008156 patent/WO1993006832A1/en not_active Ceased
- 1992-09-30 DE DE69227696T patent/DE69227696T2/de not_active Expired - Fee Related
- 1992-09-30 AU AU27557/92A patent/AU675412B2/en not_active Ceased
1994
- 1994-03-28 OA OA60486A patent/OA09917A/en unknown

Also Published As

Publication number	Publication date
JPH06511008A (ja)	1994-12-08
AU2755792A (en)	1993-05-03
AU675412B2 (en)	1997-02-06
EP0607252B1 (en)	1998-11-25
BR9206571A (pt)	1995-10-17
ATE173625T1 (de)	1998-12-15
OA09917A (en)	1994-09-15
EP0607252A4 (en)	1996-03-13
WO1993006832A1 (en)	1993-04-15
CA2120140A1 (en)	1993-04-15
EP0607252A1 (en)	1994-07-27
DE69227696D1 (de)	1999-01-07
DE69227696T2 (de)	1999-05-20
PT100914A (pt)	1993-10-29

Publication	Publication Date	Title
MX9205549A (es)	1993-05-01	Metodo para el tratamiento de vih.
ES2067314T3 (es)	1995-03-16	3-benzacepin-zonas sustituidas por un grupo benzociclobutilo o indanil-alquil-amino-alquilo, utiles en el tratamiento de las afecciones cardiovasculares.
CO4290353A1 (es)	1996-04-17	Agonistas de estrogeno
DK0582829T3 (da)	2001-10-15	9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
ES2056963T3 (es)	1994-10-16	Agentes antibacterianos.
DE69011189D1 (de)	1994-09-08	Treiber für Hochvolt-Halbbrücken-Schaltkreise.
ATE30237T1 (de)	1987-10-15	Epi-derivat von azahomoerythromycin a und zwischenprodukte.
BR9200317A (pt)	1992-10-06	Composto termoconformavel e processo para a preparacao do mesmo
ES532789A0 (es)	1985-01-16	Procedimiento para el tratamiento de napas no-tejidas
DE69010162D1 (de)	1994-07-28	Zusammensetzung zur Behandlung von Entzündung.
MX9305248A (es)	1995-01-31	Compuestos de diarilpiperazinoacetamida.
ES2083597T3 (es)	1996-04-16	Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
DK52487D0 (da)	1987-02-02	Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser
ES2013631B3 (es)	1990-05-16	Metodo para el tratamiento de tejidos.
ES520914A0 (es)	1984-11-01	Procedimiento para el tratamiento de lodos industriales residuales.
ES532696A0 (es)	1985-11-16	Procedimiento para el tratamiento de textiles
ES2187534T3 (es)	2003-06-16	Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida.
ES2134184T3 (es)	1999-10-01	Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
MX9202507A (es)	1992-11-01	Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
NZ228023A (en)	1991-10-25	24(r)-scymnol; preparatory processes and pharmaceutical compositions
MX9204286A (es)	1993-01-29	Agentes para el tratamiento de semillas.
ES2019583B3 (es)	1991-07-01	Composicion para el tratamiento de infecciones.
PT89582B (pt)	1994-01-31	Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
ES2055700T3 (es)	1994-09-01	Mezclas bactericidas.
ES1013369Y (es)	1991-05-16	Maquina elaboradora para el tratamiento de superficies de piezas de trabajo.